Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery disease

Atherosclerosis

Volumn 233, Issue 2, 2014, Pages 454-459

  Miyoshi, Toru ^a   Doi, Masayuki ^b   Usui, Shinichi ^c   Iwamoto, Mutsumi ^b   Kajiya, Masahito ^b   Takeda, Ko ^b   Nosaka, Kazumasa ^b   Nakayama, Rie ^b   Okawa, Keisuke ^b   Takagi, Wataru ^b   Nakamura, Kazufumi ^a   Hirohata, Satoshi ^c   Ito, Hiroshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Adipokine; Coronary artery disease; Inflammation; Obesity; Secreted frizzled related protein 5

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SECRETED FRIZZLED RELATED PROTEIN 5; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ADIPOCYTOKINE; ADIPOQ PROTEIN, HUMAN; EYE PROTEIN; MEMBRANE PROTEIN; SFRP5 PROTEIN, HUMAN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENSINI SCORE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; ANIMAL; BLOOD; COMORBIDITY; DOG; DYSLIPIDEMIAS; EPIDEMIOLOGY; JAPAN; MIDDLE AGED; OBESITY; RADIOGRAPHY; RISK FACTOR;

ADIPOKINES; ADIPONECTIN; AGED; ANIMALS; BODY MASS INDEX; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOGS; DYSLIPIDEMIAS; EYE PROTEINS; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; JAPAN; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OBESITY; RISK FACTORS; SMOKING;

EID: 84896282224     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.01.019     Document Type: Article

References (27)

1. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011, 11:98-107.
2. Hansson G.K., Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011, 12:204-212.
3. Kolb H., Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 2010, 53:10-20.
4. Deng Y., Scherer P.E. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci 2010, 1212:E1-E19.
5. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11:85-97.
6. Ouchi N., Higuchi A., Ohashi K., et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 2010, 329:454-457.
7. Hu Z., Deng H., Qu H. Plasma sfrp5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance. Diabetes Res Clin Pract 2013, 99:391-395.
8. Schulte D.M., Muller N., Neumann K., et al. Pro-inflammatory wnt5a and anti-inflammatory sfrp5 are differentially regulated by nutritional factors in obese human subjects. PLoS ONE 2012, 7:e32437.
9. Dan K., Miyoshi T., Ueeda M., et al. Impact of chronic kidney disease on left main coronary artery disease and prognosis in Japanese patients. Circ J 2012, 76:2266-2272.
10. Miyoshi T., Doi M., Hirohata S., et al. Cardio-ankle vascular index is independently associated with the severity of coronary atherosclerosis and left ventricular function in patients with ischemic heart disease. JAtheroscler Thromb 2010, 17:249-258.
11. Standards of medical care in diabetes - 2008. Diabetes Care 2008, 31(Suppl.1):S12-S54.
12. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. Amore accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
13. Ninomiya T., Kiyohara Y., Kubo M., et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama study. Kidney Int 2005, 68:228-236.
14. Miyoshi T., Onoue G., Hirohata A., et al. Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound. Atherosclerosis 2010, 211:164-169.
15. Doi M., Miyoshi T., Hirohata S., et al. Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men. Cardiovasc Diabetol 2011, 10:44.
16. Bottner A., Kratzsch J., Muller G., et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. JClin Endocrinol Metab 2004, 89:4053-4061.
17. Carstensen M., Herder C., Kempf K., et al. Sfrp5 correlates with insulin resistance and oxidative stress. Eur J Clin Invest 2013, 43:350-357.
18. Bird L. Inflammation: the fat controller. Nat Rev Immunol 2010, 10:540.
19. Mori H., Prestwich T.C., Reid M.A., et al. Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. JClin Invest 2012, 122:2405-2416.
20. Stienstra R., van Diepen J.A., Tack C.J., et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A 2011, 108:15324-15329.
21. Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R. Hormonal regulation of adiponectin gene expression in 3t3-l1 adipocytes. Biochem Biophys Res Commun 2002, 290:1084-1089.
22. Lv C., Jiang Y., Wang H., Chen B. Sfrp5 expression and secretion in adipocyte are upregulated during the differentiation and are negatively correlated with insulin resistance. Cell Biol Int 2012, 36:851-855.
23. Bilkovski R., Schulte D.M., Oberhauser F., et al. Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via Wnt-5a in humans. Int J Obes (Lond) 2011, 35:1450-1454.
24. Kannel W.B., D'Agostino R.B., Silbershatz H. Blood pressure and cardiovascular morbidity and mortality rates in the elderly. Am Heart J 1997, 134:758-763.
25. Glynn R.J., Field T.S., Rosner B., Hebert P.R., Taylor J.O., Hennekens C.H. Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet 1995, 345:825-829.
26. Anderson K.M., Castelli W.P., Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 1987, 257:2176-2180.
27. Olefsky J.M. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. JClin Invest 2000, 106:467-472.